Table 3– Associated valvular heart diseases in patients assessed for pulmonary hypertension (PH) associated with benfluorex
PatientType of valvular dysfunctionGradeMorphological abnormalitiesType of associated PH
1AorticMildMixed
2MitralMildMixed
3MitralMildMixed
4Mitral AorticModerate MildMitral valves sclerosisMixed
5MitralMildMitral valves thickeningMixed
6Mitral AorticMild ModerateMixed
7Mitral AorticMild ModerateMixed
8MitralMildPrecapillary
9AorticMildPrecapillary
10AorticMildPrecapillary
11MitralTrivialReduced mobility of anterior leaflet of mitral valvePrecapillary
12AorticMildPrecapillary
13Mitral AorticMild MildPrecapillary
14MitralModerateMitral valves prolapsePrecapillary
15MitralModerateThickening of anterior and posterior leaflets of mitral valve + thickened chordaePrecapillary
16MitralModerate-to-severePrecapillary
17Mitral AorticMild MildPrecapillary
18AorticMildAortic leaflets changePrecapillary
19Mitral AorticModerate MildMitral valve sclerosisPrecapillary
20AorticMildPrecapillary
21MitralMildPrecapillary
22Mitral AorticUnknown UnknownPrecapillary
23MitralMildPrecapillary